Key market opportunities include enhancing quality systems in the pharmaceutical supply chain, robust implementation of Good Distribution Practice (GDP), and combating counterfeit drug threats.
The main market opportunities arise from enhancing supply chain integrity in the pharmaceutical industry through GDP and GSP compliance. This addresses regulatory adherence, quality assurance, and ...
The "Good Distribution Practices of Pharmaceuticals and APIs Training Course (Nov 17th - Nov 18th, 2025)" training has been added to ResearchAndMarkets.com's offering. It is crucial that ...